News

One emerging treatment option for several antibody-mediated autoimmune diseases is the anti-CD38 antibody daratumumab, which depletes autoantibody-secreting plasma cells. Methods We treated two ...
The purpose of this study is to assess the effectiveness of daratumumab SC in treating patients with monoclonal immunoglobulin deposits (PGNMID) by assessing improvement in proteinuria at 12 months.
The study demonstrated that listening to patients’ self-reported assessments of their physical functioning prior to starting treatment with daratumumab can help predict how well they will respond to ...
(NewsNation) — Two major Mexican drug cartels are now stealing oil and extorting American mining firms and could be partnering together to form what federal officials are characterizing as a “super ...
in favor of the benefit-risk profile of single-agent DARZALEX FASPRO ® (daratumumab and hyaluronidase-fihj) for the treatment of adult patients with high-risk smoldering multiple myeloma (HR-SMM).
In August 2012, Janssen Biotech, Inc. and Genmab A/S entered a worldwide agreement, which granted Janssen an exclusive license to develop, manufacture and commercialize daratumumab. Systemic ...
Ashraf Z. Badros, MBChB, discussed the results from the AURIGA trial of maintenance therapy with daratumumab and lenalidomide in newly diagnosed multiple myeloma. Maintenance therapy with subcutaneous ...
In a 6 to 2 vote, the FDA’s Oncologic Drug Advisory Committee (ODAC) voted that results from the AQUILA study (NCT03301220) provides sufficient evidence to support a favorable benefit-risk ratio for ...
The contract also includes a favorable short-term cash structure and a no-trade clause, affirming the 49ers’ commitment to one of the modern NFL’s signature draft finds. We heard in late February ...
Forest structures—particularly, the canopy structure—were found to have the strongest health impact, both with its own benefits and drawbacks. Dense canopy reduces heat stress by providing ...